These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [The rationale for drug combinations in the therapy of arterial hypertension]. Salvetti A; Virdis A; Di Venanzio L Ann Ital Med Int; 1993 Oct; 8 Suppl():107S-110S. PubMed ID: 8117517 [TBL] [Abstract][Full Text] [Related]
4. [Refractory arterial hypertension--where is the refractoriness? Hic rhodus, hic salta!]. Jelaković B; Laganović M; Kuzmanić D Lijec Vjesn; 2001; 123(7-8):184-90. PubMed ID: 11729614 [TBL] [Abstract][Full Text] [Related]
5. [Insulin resistance and arterial hypertension. Major combination or a nice story?]. Passa P Rev Prat; 1992 Sep; 42(14):1787-9. PubMed ID: 1480938 [No Abstract] [Full Text] [Related]
6. [Metabolic aspects to consider in essential arterial hypertension]. Grinberg M Arq Bras Cardiol; 1991 Feb; 56(2):105-7. PubMed ID: 1872721 [No Abstract] [Full Text] [Related]
7. [Refractory arterial hypertension and the use of anticonvulsant drugs. Case report]. Downey P; Fajuri A; Valdés G Rev Med Chil; 2001 Nov; 129(11):1325-7. PubMed ID: 11836887 [TBL] [Abstract][Full Text] [Related]
9. Influence of mianserin on the activity of some hypotensive drugs in spontaneously hypertensive rats. Górska D; Andrzejczak D Pol J Pharmacol; 2003; 55(3):409-17. PubMed ID: 14506320 [TBL] [Abstract][Full Text] [Related]
10. [Nationwide drug surveillance project on slow-release nicardipine in the short-term therapy of light/moderate arterial hypertension]. Benvenuti C; Guerini Rocco C; Trezzi P Minerva Cardioangiol; 1995 Sep; 43(9):399-408. PubMed ID: 8552269 [TBL] [Abstract][Full Text] [Related]
11. Treatment resistant hypertension. Bolli P Am J Ther; 2008; 15(4):351-5. PubMed ID: 18645339 [TBL] [Abstract][Full Text] [Related]
12. [Hypotensive and metabolic effect of indapamide and perindopril in patients with type 2 diabetes and arterial hypertensia]. Askerov MM Georgian Med News; 2009 Apr; (169):44-8. PubMed ID: 19430043 [TBL] [Abstract][Full Text] [Related]
14. [The treatability of refractory or resistant hypertension by personalized antihypertensive chronotherapy based on ambulatory monitoring of the arterial pressure]. Cugini P Recenti Prog Med; 1996 Feb; 87(2):51-7. PubMed ID: 8725080 [TBL] [Abstract][Full Text] [Related]
15. Hypertension, insulin, and alpha 1-blockade. Weidmann P; Ferrari P J Clin Pharmacol; 1993 Sep; 33(9):895-9. PubMed ID: 7901245 [No Abstract] [Full Text] [Related]
16. [Factors of resistance to the treatment of hypertension. They are multiple, but often controllable, without therapeutic escalation]. Achard JM; Fournier A Rev Prat; 1993 Sep; 43(14):1813-8. PubMed ID: 8310224 [No Abstract] [Full Text] [Related]
17. [Inadequate treatment and control of arterial hypertension in patients with type 2 diabetes mellitus]. Boero R; Prodi E; Borsa S; Berti V; Fiorio E; Ferraro L; Massara C; Quarello F G Ital Nefrol; 2002; 19(4):413-8. PubMed ID: 12369043 [TBL] [Abstract][Full Text] [Related]
18. [When blood pressure control is a problem. Refractory hypertension is rare]. Offers E; Kolloch R MMW Fortschr Med; 2002 Nov; 144(46):42-4, 46. PubMed ID: 12534081 [TBL] [Abstract][Full Text] [Related]
19. [Arterial hypertension and insulin resistance: physiopathogenic and therapeutic implications]. Ribeiro AB; Zanella MT Arq Bras Cardiol; 1991 Mar; 56(3):185-8. PubMed ID: 1888284 [No Abstract] [Full Text] [Related]